Literature DB >> 16216822

Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?

Sarah J Lewis1, Shah Ebrahim, George Davey Smith.   

Abstract

OBJECTIVES: To investigate the association between the MTHFR 677C-->T polymorphism and coronary heart disease, assessing small study bias and heterogeneity between studies. DATA SOURCES: Medline and Embase citation searches between January 2001 and August 2004; no language restrictions. STUDY SELECTION: Case-control and prospective studies of association between MTHFR 677C-->T variant and myocardial infarction, coronary artery occlusion, or both; 80 studies were included. DATA EXTRACTION: Data on genotype frequency and mean homocysteine concentrations by genotype were extracted. Odds ratios were calculated for TT genotype versus CC genotype. Heterogeneity was explored, with stratification by geographical region of the study samples, and meta-regression by difference in mean serum homocysteine concentrations (CC minus TT genotypes) was carried out.
RESULTS: 26,000 cases and 31,183 controls were included. An overall random effects odds ratio of 1.14 (95% confidence intervals 1.05 to 1.24) was found for TT versus CC genotype. There was strong evidence of heterogeneity (P < 0.001, I2 = 38.4%), which largely disappeared after stratification by geographical region. Odds ratios in Europe, Australia, and North America attenuated towards the null, unlike those in the Middle East and Asia.
CONCLUSIONS: No strong evidence exists to support an association of the MTHFR 677 C-->T polymorphism and coronary heart disease in Europe, North America, or Australia. Geographical variability may be due to higher folate intake in North America and Europe or to publication bias. The conclusion drawn from previous meta-analyses that folic acid, through lowering homocysteine, has a role in prevention of cardiovascular disease is in some doubt.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216822      PMCID: PMC1283183          DOI: 10.1136/bmj.38611.658947.55

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  26 in total

1.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?

Authors:  George Davey Smith; Shah Ebrahim
Journal:  Int J Epidemiol       Date:  2003-02       Impact factor: 7.196

2.  MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

Authors:  Mariska Klerk; Petra Verhoef; Robert Clarke; Henk J Blom; Frans J Kok; Evert G Schouten
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

Review 3.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

4.  Current status of prenatal management of fetal spina bifida in the world: worldwide cooperative survey on the medico-ethical issue.

Authors:  Shizuo Oi
Journal:  Childs Nerv Syst       Date:  2003-08-06       Impact factor: 1.475

Review 5.  Problems of reporting genetic associations with complex outcomes.

Authors:  Helen M Colhoun; Paul M McKeigue; George Davey Smith
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

Review 6.  Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal?

Authors:  G Davey Smith; R Harbord; S Ebrahim
Journal:  QJM       Date:  2004-03

7.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

Authors:  David S Wald; Malcolm Law; Joan K Morris
Journal:  BMJ       Date:  2002-11-23

8.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

9.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28

10.  Prevalence and role of methylenetetrahydrofolate reductase 677 C-->T and 1298 A-->C polymorphisms in coronary artery disease in Arabs.

Authors:  Khaled K Abu-Amero; Carol A Wyngaard; Nduna Dzimiri
Journal:  Arch Pathol Lab Med       Date:  2003-10       Impact factor: 5.534

View more
  80 in total

1.  Pathway-based genome-wide association analysis of coronary heart disease identifies biologically important gene sets.

Authors:  Lisa de las Fuentes; Wei Yang; Victor G Dávila-Román; C Charles Gu
Journal:  Eur J Hum Genet       Date:  2012-04-18       Impact factor: 4.246

2.  Folate network genetic variation predicts cardiovascular disease risk in non-Hispanic white males.

Authors:  Susan M Wernimont; Andrew G Clark; Patrick J Stover; Martin T Wells; Augusto A Litonjua; Scott T Weiss; J Michael Gaziano; Pantel S Vokonas; Katherine L Tucker; Patricia A Cassano
Journal:  J Nutr       Date:  2012-05-30       Impact factor: 4.798

3.  Functional inference of the methylenetetrahydrofolate reductase 677C > T and 1298A > C polymorphisms from a large-scale epidemiological study.

Authors:  Arve Ulvik; Per M Ueland; Ase Fredriksen; Klaus Meyer; Stein Emil Vollset; Geir Hoff; Jørn Schneede
Journal:  Hum Genet       Date:  2006-11-18       Impact factor: 4.132

Review 4.  [Vegetarian nutrition: preventive potential and possible risks. Part 2: animal foods and recommendations].

Authors:  Alexander Ströhle; Annika Waldmann; Maike Wolters; Andreas Hahn
Journal:  Wien Klin Wochenschr       Date:  2006-12       Impact factor: 1.704

Review 5.  Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence.

Authors:  David S Wald; Nicholas J Wald; Joan K Morris; Malcolm Law
Journal:  BMJ       Date:  2006-11-25

6.  A direct assessment of genetic contribution to the incidence of coronary infarct in the general population Greek EPIC cohort.

Authors:  Nikos Yiannakouris; Antonia Trichopoulou; Vassiliki Benetou; Theodora Psaltopoulou; Jose M Ordovas; Dimitrios Trichopoulos
Journal:  Eur J Epidemiol       Date:  2006-11-22       Impact factor: 8.082

Review 7.  Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?

Authors:  Shah Ebrahim; George Davey Smith
Journal:  Hum Genet       Date:  2007-11-23       Impact factor: 4.132

8.  The association between elevated levels of inflammation biomarkers and coronary artery disease and death.

Authors:  Gordon D O Lowe
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

9.  Mendelian randomisation study of the associations of vitamin B12 and folate genetic risk scores with blood pressure and fasting serum lipid levels in three Danish population-based studies.

Authors:  L L N Husemoen; T Skaaby; B H Thuesen; N Grarup; C H Sandholt; T Hansen; O Pedersen; A Linneberg
Journal:  Eur J Clin Nutr       Date:  2016-02-24       Impact factor: 4.016

10.  MTHFR C677T genotype and cardiovascular risk in a general population without mandatory folic acid fortification.

Authors:  Lise Lotte N Husemoen; Tea Skaaby; Torben Jørgensen; Betina H Thuesen; Mogens Fenger; Niels Grarup; Camilla H Sandholt; Torben Hansen; Oluf Pedersen; Allan Linneberg
Journal:  Eur J Nutr       Date:  2014-01-24       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.